212 related articles for article (PubMed ID: 20838345)
1. Cardiovascular aspects of antipsychotics.
Raedler TJ
Curr Opin Psychiatry; 2010 Nov; 23(6):574-81. PubMed ID: 20838345
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of antipsychotics.
Michelsen JW; Meyer JM
Expert Rev Neurother; 2007 Jul; 7(7):829-39. PubMed ID: 17610390
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
4. Atypical antipsychotics: enhancing healthy outcomes.
Casey DE
Arch Psychiatr Nurs; 2002 Jun; 16(3 Suppl 1):S12-9. PubMed ID: 12046020
[No Abstract] [Full Text] [Related]
5. Cardiovascular risks of atypical antipsychotic drug treatment.
Drici MD; Priori S
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
[TBL] [Abstract][Full Text] [Related]
6. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
Monteleone P; Martiadis V; Maj M
Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
[TBL] [Abstract][Full Text] [Related]
7. Serious cardiovascular events and mortality among patients with schizophrenia.
Enger C; Weatherby L; Reynolds RF; Glasser DB; Walker AM
J Nerv Ment Dis; 2004 Jan; 192(1):19-27. PubMed ID: 14718772
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
9. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
Yogaratnam J; Biswas N; Vadivel R; Jacob R
East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
[TBL] [Abstract][Full Text] [Related]
10. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder.
McIntyre RS; Konarski JZ
J Clin Psychiatry; 2005; 66 Suppl 3():28-36. PubMed ID: 15762832
[TBL] [Abstract][Full Text] [Related]
11. Risk of cardiovascular disease and sudden death in schizophrenia.
Davidson M
J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 4():8-13. PubMed ID: 17539694
[TBL] [Abstract][Full Text] [Related]
13. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Meltzer HY; Davidson M; Glassman AH; Vieweg WV
J Clin Psychiatry; 2002; 63 Suppl 9():25-9. PubMed ID: 12088173
[TBL] [Abstract][Full Text] [Related]
14. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
15. Life expectancy and cardiovascular mortality in persons with schizophrenia.
Laursen TM; Munk-Olsen T; Vestergaard M
Curr Opin Psychiatry; 2012 Mar; 25(2):83-8. PubMed ID: 22249081
[TBL] [Abstract][Full Text] [Related]
16. A review of clozapine safety.
Fitzsimons J; Berk M; Lambert T; Bourin M; Dodd S
Expert Opin Drug Saf; 2005 Jul; 4(4):731-44. PubMed ID: 16011451
[TBL] [Abstract][Full Text] [Related]
17. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
Newcomer JW
J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia and antipsychotic medications.
Haupt DW; Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
[TBL] [Abstract][Full Text] [Related]
19. [Response to the position of the "Biological Psychiatry" Working Group of the Federal Directors Conference--Association of Executive Physicians of Psychiatry and Psychotherapy Clinics (BDK) e.V].
Aderhold V
Psychiatr Prax; 2009 Mar; 36(2):94-5. PubMed ID: 19358097
[No Abstract] [Full Text] [Related]
20. Cardiovascular disease in patients with schizophrenia.
Kritharides L; Chow V; Lambert TJ
Med J Aust; 2017 Feb; 206(2):91-95. PubMed ID: 28152356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
